American Society of Ketamine Physicians - 2019 ASKP Annual Conference

Thu, September 19 2019, 6:00 PM - Sat, September 21 2019, 5:00 PM [MST]

6700 North Gaylord Rockies Boulevard, Aurora, CO, 80019, United States

REGISTER NOW

1. Select Seats

2. Review and Proceed

Sale ended

The American Society of Ketamine Physicians Annual Conference - Early Bird Partial Approval -$600.00

ASKP Members receive $100 off ticket price. Please check your email for details.

Enter your discount code

  • Subtotal (excluding fees and discounts)
  • Fee
  • Total amount

Event Information

Thu, September 19 2019, 6:00 PM - Sat, September 21 2019, 5:00 PM [MST]

About the Event

This is the second annual conference for the American Society of Ketamine Physicians.  A conference involving multi-disciplinary speakers discussing ketamine use for mood disorders, psychotherapy and pain conditions.  We will cover the most current science concerning mechanism of actions, dosing protocols, use in addiction and more.  Our speakers include Dr. Amit Anand, Dr. Sanjay Mathew and other leaders in the field.  Please join us for this educational conference and extraordinary networking experience. 
This conference is sure to sell out so be sure to register soon!

Event Location

About the Organizer

The American Society of Ketamine Physicians is a group of professionals dedicated to the safe clinical use of ketamine for mental health disorders and pain conditions. To get involved or apply for membership, please visit www.askp.org

CONTACT ORGANIZER

Event Speakers

Lori Calabrese, MD was educated at The Johns Hopkins University School of Medicine, completed residency training at Massachusetts General Hospital/Harvard Medical School. She served as clinical faculty at MGH/Harvard Medical School and as Clinical Assistant Professor of Psychiatry at Yale. She loves patient care, and has worked in private practice in the Hartford area for more than 20 years. Dr. Calabrese was the first physician in CT to offer IV ketamine infusions for treatment resistant depression in her practice, Innovative Psychiatry, as part of a full array of psychiatric treatment options in an office setting. She has a keen interest in treating acute and chronic suicidal ideation with ketamine infusions. In 2018, she presented preliminary data using IV ketamine to treat suicidal outpatients in psychiatric private practice at the First International Conference for Ketamine and Related Compounds for Psychiatric Disorders in Oxford, UK. She has presented the results of her ongoing work using serial, titrated ketamine infusions for suicidal ideation at KRIYA Conference 2018 in San Francisco, California, at the 6th World Congress on Mental Health, Psychiatry and Wellbeing 2019 in New York, and at the APA 2019 Annual Meeting in San Francisco. She will also be speaking at the 2019 International Summit on Suicide Research in Miami in October, 2019.

https://loricalabresemd.com/meet-lori-calabrese/
Gerard Sanacora, PhD, MD
George D. and Esther S. Gross Professor of Psychiatry; Director, Yale Depression Research Program; Co-Director, Yale New Haven Hospital Interventional Psychiatry Service

Dr. Sanacora is currently an Associate Professor and the Director of the Yale Depression Research Program. Dr. Sanacora’s work is concentrated largely on elucidating the pathophysiological mechanisms associated with mood and other neuropsychiatric disorders. Much of his recent research has focused on identifying the contributions of the amino acid neurotransmitter systems (GABA and Glutamate) to the neurobiology of mood disorders and the mechanism of antidepressant action.

https://medicine.yale.edu/psychiatry/research/programs/clinical_people/gerard_sanacora-1.profile
Amit Anand, MD
Professor of Medicine at the Cleveland Clinic Lerner College of Medicine

Professor of Medicine at the Cleveland Clinic Lerner College of Medicine; Vice-chair for Research for the Center for Behavioral Health; Director, Mood and Emotional Disorders Across the Life Span (MEDALS) program, Cleveland Clinic

https://my.clevelandclinic.org/staff/17248-amit-anand#biography
Jeffrey Becker, MD
Adult Psychiatry and Wellness

Dr. Jeffrey Becker trained at UCLA/NPI in both Medicine and Psychiatry with a focus on Neuropsychiatry and Functional Medicine. He is board-certified through the American Board of Psychiatry and Neurology (ABPN) and the American Board for Integrative and Holistic Medicine (ABIHM). He maintains clinical offices in Los Angeles and Santa Barbara and is affiliated with UCLA/NPI as Volunteer Clinical Faculty. Dr. Becker’s integrative and holistic approach to psychiatry examines mind and brain function in reference to the health of the whole body. He combines conventional medicine with evidence-based nutrients, lifestyle modifications, and complimentary treatments to restore synergy and balance to baseline physiology. Clinical presentation, past medical history, laboratory results and genetic studies are examined to customize an individualized treatment plan designed specifically to promote optimal health and improve medical and psychiatric outcomes for each patient.

http://www.jeffreybeckermd.com/
Rachel Dalthorp M.D.
Diplomate American Board of Psychiatry and Neurology

Dr. Rachel Dalthorp received her medical degree from the University of Oklahoma College of Medicine in 2010 followed by a a four-year psychiatric residency where she focused on developing expertise in the sub-specialty of reproductive psychiatry. She owns a private practice in the Oklahoma City area called Balance Women’s Health. In 2015 she developed an interest in interventional treatments for psychiatric disorders, specifically treatment resistant depression, and began providing ketamine infusion therapy. Dr. Dalthorp has provided more than 4000 infusions. Her expertise in hormone related mood disorders and experience treating patients with Ketamine infusions led to an interest in understanding how hormones might impact infusion results and efforts to modify treatment to improve response rates.

http://ketamineok.com
Jessica Katzman, Psy.D
Clinical Psychologist

Dr. Jessica Katzman, Psy.D. is a Clinical Psychologist licensed in California. She co-founded Healing Realms, a center for depth-oriented ketamine assisted psychotherapy, with Dr. Robert Grant in 2017, following an advanced training in therapeutic ketamine with the KRIYA Institute. She also organizes a local consultation group for ketamine assisted psychotherapy providers in the Bay Area. Dr. Katzman has 20 years of experience as a therapist and supervisor, including a decade providing harm reduction and disability evaluation services in a community mental health setting. In her private practice, she specializes in mood and anxiety disorders, chronic and complex PTSD, addressing alcohol and substance use from a harm reduction lens, supporting the LGBTQ community, assessments for gender transition procedures, and assisting those integrating psychedelic experiences.

https://www.healingrealmscenter.com

Vice Chair for Research; Baylor College of Medicine; Professor of Psychiatry and Behavioral Sciences; Marjorie Bintliff Johnson and Raleigh White Johnson, Jr. Chair for Research in Psychiatry; Menninger Department of Psychiatry & Behavioral Sciences; Baylor College of Medicine; Houston, TX, US; Director; Mood and Anxiety Disorders Program; Baylor College of Medicine; Houston, Texas, United States; Staff Physician; Michael E. DeBakey VA Medical Center;

https://www.bcm.edu/people/view/sanjay-mathew-m-d/b25b1938-ffed-11e2-be68-080027880ca6
Daniel Richman, MD
Anesthesiologist and Pain Management Physician

Attending Anesthesiologist and Pain Management Physician - Hospital for Special Surgery Assistant Attending and Clinical Instructor - Tri-Institutional Pain Management Fellowship, New York-Presbyterian Hospital and Memorial Sloan Kettering Cancer Center.

https://www.hss.edu/physicians_richman-daniel.asp
Omid J Naim, M.D.
Founder & Director, Psychiatry

As the founder of La Maida Institute, Omid is proud to share his vision of a “communal model for preventive health.” On a day-to-day basis, he moves between seeing patients in his clinic, Hope Integrative Psychiatry, and serving as the creative director of La Maida, supporting its growth and development through collaboration and teamwork.

https://lamaida.org/who-we-are/
David Sheehan, M.D., M.B.A.
Distinguished University Health Professor Emeritus

David V. Sheehan M.D., M.B.A. is recognized as one of the world’s leading researchers in anxiety disorders. He has written over 500 abstracts and 300 publications including a bestseller The Anxiety Disease.

https://www.linkedin.com/in/davidsheehanmdmba/

Photo Gallery